Search Results for: cancer stem cell
New Walgreens shopping list: q-tips, aspirin, & cutting-edge gene & cell therapies
It takes a lot to surprise me these days in the cell therapy and regenerative medicine space, but some news from Walgreens stopped me in my tracks yesterday. The firm most well known for its drug stores and pharmacies has been struggling recently. Perhaps as a way to try to turn things around, they recently …
New Walgreens shopping list: q-tips, aspirin, & cutting-edge gene & cell therapies Read More »
Recent stem cell & regenerative medicine good news
Looking for some stem cell good news? You’ll like today’s post. One mission of this blog The Niche is to promote rigorous science-based regenerative medicine, which can lead to investigating and writing about not-so-upbeat stuff. Risky clinics. People getting hurt. Patient lawsuits. Serious FDA, FTC, or state AG regulatory developments. Such actions can be good …
Recent stem cell & regenerative medicine good news Read More »
US clinics selling unproven RGCC cell therapies in addition to SOT
I wrote a few weeks ago about a firm called RGCC or Research Genetic Cancer Center, which sells what I see as an unproven RNA therapy to clinics throughout the US. The approach is called supportive oligonucleotide therapy or SOT. After buying it from RGCC, the clinics then sell SOT injections for Lyme disease, other …
US clinics selling unproven RGCC cell therapies in addition to SOT Read More »
Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP
When a vendor of important reagents like antibody supplier Abcam charges big money, those high Abcam prices could negatively impact research in the long run. Some of the prices are so high that buying just a few antibodies could take up a small but meaningful slice of an entire R01 grant. Sky-high Abcam prices I’ve …
Weekly reads: abundant Abcam prices, speedy aging & cancer, stemmy CAR-T, more on STAP Read More »
Weekly reads: immune rejuvenation, Cryo-Cell spin-off, stem cell patches, direct reprogramming
What is immune rejuvenation? How would that work and what would be the benefits? As we age, our immune systems can change in unhelpful and unhealthy ways. One such change is a drift in the balance of production of different kinds of immune cells. Such a shift can lead to too many of some immune …
Weekly reads: Alzheimer’s & lipid droplets, stem cells for COPD, fecal tx warning, med school teaching
So many things go wrong during the lead up to clinically-evident Alzheimer’s disease. This complex disease pathway has, in turn, led to a vast array of approaches to try to treat or prevent Alzheimer’s. Most of these efforts one way or another have something to do with the amyloid plaques and tangles that accumulate in the …
Key Mayo Clinic stem cell webpage is overexuberant & outdated
The Mayo Clinic does some great research on stem cells and regenerative medicine. However, at times I’ve felt that a few Mayo researchers are overexuberant. This mainly relates to certain not-yet-proven stem cell and related offerings. Fitting with that perception, the Mayo website also has some inaccurate stem cell content that leans toward overstating things. …
Key Mayo Clinic stem cell webpage is overexuberant & outdated Read More »
Weekly reads: elephant stem cells, RIP Connie Eaves, AI cell biology
Last week one of the most popular stories was about a preprint from a mammoth de-extinction research group led by George Church having made elephant stem cells. I finally got a chance to look carefully at their preprint. Elephant stem cells preprint and mammoth de-extinction The elephant stem cells preprint has solid data. It looks like …
Weekly reads: elephant stem cells, RIP Connie Eaves, AI cell biology Read More »
Weekly reads: anti-aging tricks & treats, stealthy stem cells, Mammoth de-extinction milestone
Anti-aging might already be the big regenerative medicine story of 2024 and it’s only early March. Anti-aging hype going to the dogs? One of my 20 stem cell and regenerative medicine predictions for 2024 was that longevity would continue to make big news including in some not-so-great ways. In just over two months there has …